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PEndothelial Dysfunction
ssociation of Helicobacter pylori
nfection With Systemic Inflammation and
ndothelial Dysfunction in Healthy Male Subjects
etsuya Oshima, MD, PHD,* Ryoji Ozono, MD, PHD,* Yoko Yano, MD,* Yoshihiko Oishi, MD, PHD,*
iroki Teragawa, MD, PHD,† Yukihito Higashi, MD, PHD,‡ Masao Yoshizumi, MD, PHD,‡
asayuki Kambe, MD, PHD*
iroshima, Japan
OBJECTIVES The goal of the present study was to determine whether seropositivity to Helicobacter pylori
(HP), Chlamydia pneumoniae (CP), and cytomegalovirus (CMV) is associated with systemic
inflammation and endothelial dysfunction in healthy male subjects.
BACKGROUND Chronic infection with certain bacteria and viruses may play an important role in inflamma-
tion as the pathogenesis of atherosclerosis.
METHODS The serum levels of immunoglobulin G antibodies to HP, CP, CMV, high-sensitivity
C-reactive protein, soluble intercellular adhesion molecule-1, and soluble vascular cell
adhesion molecule-1 were determined in 81 healthy Japanese men (40  10 years of age).
High-frequency ultrasonographic imaging of the brachial artery was used to study
endothelium-dependent (flow-mediated vasodilation) and endothelium-independent
(nitroglycerin-induced) vasodilation.
RESULTS Prevalences of seropositive antibodies to HP, CP, and CMV were 67.9%, 61.7%, and 56.8%,
respectively. Infection with HP, CP, or CMV had no relationship with age, blood pressure,
or level of serum glucose, lipid, or soluble vascular cell adhesion molecule-1. The levels of
C-reactive protein and soluble intercellular adhesion molecule-1 were significantly higher,
and flow-mediated vasodilation was significantly lower in subjects with seropositive antibod-
ies to HP than in subjects with seronegative antibodies to HP. Endothelium-independent
vasodilation was similar in both groups.
CONCLUSIONS Chronic infection with HP may be involved in_the development of the atherosclerosis via
endothelial dysfunction and systemic and vascular inflammation. (J Am Coll Cardiol 2005;




















wany observational studies have indicated that an elevated
evel of C-reactive protein (CRP), a sensitive marker of
ystemic inflammation, is independently associated with
uture risk of coronary heart diseases and stroke (1), sup-
orting the hypothesis that inflammation plays an impor-
ant role in the pathogenesis of atherosclerosis (2). Leuko-
yte binding to cellular adhesion molecules on the surface of
ascular endothelium in response to many inflammatory
ytokines and CRP may be the earliest event in vascular
nflammatory process (2). These circulating molecules, such
s soluble intercellular adhesion molecule (sICAM)-1 and
oluble vascular cell adhesion molecule (sVCAM)-1, may
erve as markers of endothelial activation and vascular
nflammation (3).
Much attention has been given to the possibility that
ertain infectious agents predispose a person to inflamma-
ion and atherosclerosis (4). Many seroepidemiologic stud-
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orted by a Grant-in-Aid for Scientific Research from the Ministry of Education,
cience, and Culture of Japan (15390177).G
Manuscript received August 4, 2004; revised manuscript received December 8,
004, accepted January 4, 2005.es have shown associations between previous infections
ith Helicobacter pylori (HP) (5,6), Chlamydia pneumoniae
CP) (7), and cytomegalovirus (CMV) (8) and the presence
f atherosclerosis in coronary, carotid, or peripheral vessels.
According to the response-to-injury hypothesis of ath-
rosclerosis, endothelial dysfunction is the first step in
therosclerosis (2). This hypothesis has been supported by
any studies, indicating that endothelial dysfunction occurs
n subjects with classic risk factors such as hypertension,
iabetes mellitus, hypercholesterolemia, and smoking (9). If
nfectious agents are involved in the pathogenesis of ath-
rosclerosis, a significant association may exist of endothelial
ysfunction with markers of infection or inflammation.
herefore, the aim of the present study was to determine
hether seropositivity to HP, CP, and CMV is associated
ith elevated levels of CRP, sICAM-1, and sVCAM-1 and
ndothelial dysfunction in healthy subjects without estab-
ished risk factors for atherosclerosis.
ETHODS
ubjects. The subjects comprised 81 Japanese men who
ere recruited from staff of the Hiroshima University































































































1220 Oshima et al. JACC Vol. 45, No. 8, 2005
Helicobacter pylori and Endothelial Dysfunction April 19, 2005:1219–22riends, and volunteers. All subjects were asymptomatic,
ifelong nonsmokers, had no clinical evidence of cardiovas-
ular disease, other serious diseases, hypertension, diabetes
ellitus, or hyperlipidemia. This study was approved by the
thics Committee of the Hiroshima University Faculty of
edicine. Informed consent for participation in the study
as obtained from all subjects.
aboratory analyses. Routine chemical methods were used
o determine serum concentrations of cholesterol, triglycer-
de and glucose, and hemoglobin A1c. Serum levels of CRP
ere measured by a highly sensitive nephelometric assay
sing a monoclonal antibody to CRP (Dade Behring,
eerfield, Illinois) with the lowest detection point of 0.2
g/l. Serum levels of sICAM-1 and sVCAM-1 were
etermined by commercially available enzyme-linked im-
unosorbent assays (R & D Systems, Minneapolis,
innesota).
Commercially available kits were used to determine
erum immunoglobulin G (IgG) antibodies to infectious
gents. The HP-specific IgG was measured by an enzyme-
inked immunosorbent assay kit (Enteric Products Inc.,
estbury, New York). Enzyme-linked immunosorbent as-
ay kits were used to determine serum IgG antibodies to
MV (Denka Seiken Co., Ltd., Tokyo, Japan). Serum IgG
ntibody against CP were determined by an enzyme-linked
mmunosorbent assay using chlamydial outer membrane
omplex as an antigen (Hitachi Chemical Co., Ltd, Tokyo,
apan). Seropositivity was decided according to the recom-
endation of the manufacturers.
ltrasound studies of the brachial artery. High-resolution
ltrasonography (Philips, SONOS 550, Amsterdam, the
etherlands) and a broad-band (8- to 15-MHz) linear array
ransducer were used to measure changes in arterial diam-
ter in response to increased flow (flow-mediated vasodila-
ion [FMD]) and to sublingual nitroglycerin spray (400 g).
he brachial artery 2 to 10 cm above the antecubital fossa
as scanned in longitudinal section. Increased flow was
aken by inflation of a pneumatic tourniquet placed around
he forearm to a pressure of 250 mm Hg followed by
eflation after 5 min. Flow was calculated from Doppler
ow velocity and vessel diameter. Reactive hyperemia was
alculated as the maximum flow after cuff deflation. The
ntraobserver coefficient of variation was 3.0% for FMD and
Abbreviations and Acronyms
CMV  cytomegalovirus
CP  Chlamydia pneumoniae
CRP  C-reactive protein
FMD  flow-mediated vasodilation
HP  Helicobacter pylori
IgG  immunoglobulin G
sICAM  soluble intercellular adhesion molecule
sVCAM  soluble vascular cell adhesion molecule.5% for nitroglycerin response. wtatistical analysis. All data are expressed as means  SD.
ifferences between means were compared by the Mann-
hitney U test. Categorical data were analyzed by the
hi-square test. A p value 0.05 was considered statistically
ignificant. Univariate correlations were performed using
earson’s correlation coefficient.
ESULTS
haracteristics of subjects. Eighty-one men were enrolled
n this study. The average age was 40  10 years. Mean
ody mass index was 21.8  1.2 kg/m2. Mean systolic and
iastolic blood pressure was 118  10/72  8 mm Hg.
ean lipid values were as follows: total cholesterol, 4.7 
.6 mmol/l; low-density lipoprotein, 2.5  0.4 mmol/l;
igh-density lipoprotein, 1.6  0.3 mmol/l; and triglycer-
des, 1.3  0.3 mmol/l. Fasting glucose was 5.6  0.4
mol/l, and hemoglobin A1c was 5.2 0 .3%. Mean CRP
as 1.92  0.7 mg/l, sICAM-1 was 322  76 ng/ml, and
VCAM-1 was 417  99 ng/ml. The prevalences of
eropositivity to HP, CP, and CMV were 67.9%, 61.7%,
nd 56.8%, respectively. Five subjects were negative for all
hree pathogens. Twenty-one subjects had previous expo-
ure to one pathogen, 34 to two pathogens, and 21 to three
athogens.
The basal diameter of the brachial artery was 4.1 0.4 mm,
MD was 9.6  2.0%, and the response to nitroglycerin was
2.6  1.8%. Basal blood flow was 43  16 ml/min, and
yperemic blood flow was 260  41 ml/min.
nfection, inflammation, and laboratory variables. Base-
ine characteristics stratified by seropositivity status to
P are summarized in Table 1. No significant difference
as found in age, blood pressure, serum lipid, glucose
etabolisms, or sVCAM-1 between HP-seropositive and
seronegative groups. The levels of CRP and sICAM-1
ere significantly higher in subjects seropositive to HP than
n subjects seronegative to HP. Prevalences of seropositivity
o CMV and CP were similar in the HP-seropositive and
seronegative groups. No difference was found in each param-
ter between subjects seropositive and seronegative to CMV or
P. Age was not correlated with the infectious burden.
Normal reference laboratory values of CRP in Hiroshima
niversity Hospital are 1.3 mg/l. The frequency of
ositive antibodies to HP was significantly greater in 30
ubjects with high CRP (1.3 mg/l) than in 51 subjects
ith normal CRP (1.3 mg/l; 90% vs. 55%, p  0.003).
revalences of seropositivity to CMV (60% vs. 55%) and
P (66% vs. 59%) were similar in the groups with high
RP and normal CRP. Serum level of high-sensitivity CRP
as positively and significantly correlated with the titer of
ntibodies to HP (r  0.34, p  0.01) but not to that to
MV or CP, or the total infectious burden. Serum CRP
as significantly correlated with serum sICAM-1 (r 0.37,
 0.01) but not with sVCAM-1.
nfection and vascular function. The FMD vasodilation
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ound between subjects seropositive and seronegative to
MV or CP. No significant difference in basal or peak
yperemic blood flow was found between subjects divided
y seropositivity status to each pathogen. Basal diameter of
he brachial artery and its response to nitroglycerin were
imilar in subjects with and without infection with each
athogen. The FMD or the response to nitroglycerin was
ot correlated with age, body mass index, blood pressure,
erum lipids, serum glucose, hemoglobin A1c, serum CRP,
ICAM-1, sVCAM-1, or the total infectious burden.
ISCUSSION
eroepidemiologic studies have shown that atherosclerosis is
ssociated with several infectious pathogens, including HP
5,6), CP (7), and CMV (8). In addition, CRP, a sensitive
arker of systemic inflammation, is well recognized as an
ndependent predictor of coronary heart diseases (1). In the
resent study, we found that only seropositivity to HP of the







ge (yrs) 40  12 41  15
ystolic blood pressure (mm Hg) 117  9 119  11
iastolic blood pressure (mm Hg) 73  7 71  8
otal cholesterol (mmol/l) 4.6  0.5 4.7  0.7
DL (mmol/l) 2.4  0.4 2.5  0.5
DL (mmol/l) 1.5  0.3 1.6  0.4
riglycerides (mmol/l) 1.3  0.3 1.3  0.4
asting glucose (mmol/l) 5.7  0.4 5.5  0.5
emoglobin A1c (%) 5.2  0.3 5.2  0.3
RP (mg/l) 1.1  1.1 2.3  2.3*
ICAM-1 (ng/ml) 220  62 370  89*
VCAM-1 (ng/ml) 412  102 420  92
eropositivity to CP (%) 64.3 61.5
eropositivity to CMV (%) 58.9 61.5
p  0.05 vs. seronegative.
CMV  cytomegalovirus; CP  Chlamydia pneumoniae; CRP  C-reactive
rotein; HDL  high-density lipoprotein; HP  Helicobacter pylori; LDL 
ow-density lipoprotein; sICAM  soluble intracellular adhesion molecule-1;
VCAM  soluble intracellular adhesion molecule-1.





HP 4.12  0.44 4.08  0.40 11
CP 4.10  0.50 4.10  0.44 9
CMV 4.07  0.40 4.13  0.49 9
Basal Blood Flow (ml/min
() (
HP 42  15 44 
CP 43  20 43 
CMV 42  14 45 
*p  0.05 vs. ().
CMV  cytomegalovirus; CP  Chlamydia pneumoniae; FMD
NTG  nitroglycerin; ()  seropositive; ()  seronegative.hree infections markers tested was associated with elevated
RP. C-reactive protein was elevated in subjects seroposi-
ive to HP. Prevalence of seropositivity to HP was signifi-
antly increased in subjects with high CRP. Furthermore,
erum CRP level was positively correlated with anti-HP
ntibody titer level. Therefore, chronic infection with HP
ay account for, at least in part, the elevated serum CRP
evel in Japanese subjects. Circulating soluble form of
CAM-1, which is expressed on the activated endothelium
n response to inflammatory cytokines, also was elevated in
ubjects seropositive to HP. Chronic infection with HP may
e associated with systemic and vascular inflammation.
The second finding in the present study was an associa-
ion of HP infection with endothelial dysfunction. FMD
as attenuated in subjects seropositive to HP. This associ-
tion remained significant after adjusting for age, body mass
ndex, blood pressure, serum lipids, glucose, and CRP. The
asal diameter and reactive hyperemia in the brachial artery
ere similar in both groups, indicating no difference in the
ow stimulus. In subjects with seropositivity to HP,
ndothelium-independent vasodilation was preserved. This
nding indicates that infection with HP may have no effect
n the vascular smooth muscle function.
Only a few clinical studies have been published on the
ssociation between endothelial function and infection with
P. Prasad et al. (10) reported that attenuation of the
oronary vasodilator response to acetylcholine, an index of
ndothelial function, was observed in subjects seropositive
o HP but not in subjects seropositive to CMV or CP. This
nding is similar to our finding. However, Khairy et al. (11)
eported that no association was found between chronic
nfection with CP, CMV, or HP and FMD in healthy
oung men. Because their population was much younger
29.3  5.5 years), the low seroprevalence value for HP
14.3%) may fail to detect a true effect on endothelial
unction. Grahame-Clarke et al. (12) reported that the
esponse of forearm blood flow assessed by venous occlusion
lethysmography to bradykinin and glyceryl trinitrate were
ttenuated in young diabetic patients with CMV seroposi-
ivity but was not affected by positive serology for HP or
FMD (%) NTG (%)
() () ()
2.6 8.9  2.0* 12.6  1.8 12.6  1.4
1.9 9.7  1.2 12.2  1.8 13.0  2.6
2.1 9.9  2.0 12.4  1.6 12.8  1.8
Hyperemic Blood Flow (ml/min)
() ()
252  41 264  36
257  48 262  40
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iabetes.
There are several possibilities for the mechanism under-
ying a causal role of HP infection in endothelial dysfunc-
ion. First, HP may have the direct effect on the structure
nd function of vascular endothelial cells. Extract of HP has
een reported to induce a disturbance of proliferation and
poptosis and to decrease viability of cultured vascular
ndothelial cells (13). The second possibility is the nutri-
ional effect of HP (14). An infection from HP may cause
alabsorption of folate, vitamin B6, and vitamin B12. This
utritional defect could lead to failure of methylation by
-methyl-tetrahydrofolic acid and, thus, to hyperhomocys-
einanemia, which is toxic to endothelial cells.
Because we could not find any relation of previous
nfection with CMV or CP to CRP, sICAM-1, FMD or
ascular dilatory function, these infectious agents may not
lay an important role in chronic inflammation or dysfunc-
ion of the vascular endothelium or smooth muscle. How-
ver, many studies have shown significant association of
MV and CP infections with increased risk of myocardial
nfarction, coronary death, and stroke (5,8,9). One of the
ossible reasons for this discrepancy is the difference in
tudied subjects or race. Because our studied subjects were
ealthy, these pathogens may interact with classical risk
actors rather than having independent effects or might play
role in the later stages of atherosclerosis.
tudy limitations. Several other infectious agents are as-
ociated with endothelial dysfunction, inflammation, and
therosclerosis. These include Epstein-Barr virus, herpes
implex virus, and hepatitis A virus, among others (15).
ecause these microorganisms were not included in the
resent study, there is a possibility that we could not find the
mpact of total pathogen burden.
onclusions. We demonstrated high levels of serum CRP
nd sICAM-1 and attenuated FMD in healthy Japanese
en who were seropositive to HP in comparison with those
n seronegative subjects. Seropositivity to CMV or CP was
ot related to these parameters. We hypothesize that
hronic infection with HP directly or indirectly induces a
ersisting systemic and vascular inflammation and endothe-
ial dysfunction.eprint requests and correspondence to: Dr. Tetsuya Oshima,
epartment of Clinical Laboratory Medicine, Hiroshima Univer-
ity Graduate School of Biomedical Sciences, 1-2-3 Kasumi,
inami-ku, Hiroshima, Japan. E-mail: teto@hiroshima-u.ac.jp.
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